153 related articles for article (PubMed ID: 10189515)
1. Course of substance abuse in patients with and without schizophrenia.
Westermeyer JJ; Schneekloth TD
Am J Addict; 1999; 8(1):55-64. PubMed ID: 10189515
[TBL] [Abstract][Full Text] [Related]
2. Comorbid schizophrenia and substance abuse: a review of epidemiology and course.
Westermeyer J
Am J Addict; 2006; 15(5):345-55. PubMed ID: 16966190
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Course of Clients With Co-occurring Schizophrenia-Spectrum and Substance Use Disorders in Urban Mental Health Centers: A 7-Year Prospective Study.
Drake RE; Luciano AE; Mueser KT; Covell NH; Essock SM; Xie H; McHugo GJ
Schizophr Bull; 2016 Jan; 42(1):202-11. PubMed ID: 26294706
[TBL] [Abstract][Full Text] [Related]
4. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
Westermeyer J; Thuras P
Am J Drug Alcohol Abuse; 2005; 31(1):93-110. PubMed ID: 15768573
[TBL] [Abstract][Full Text] [Related]
5. Processing of social emotion in patients with schizophrenia and substance use disorder: an fMRI study.
Potvin S; Mancini-Marie A; Fahim C; Mensour B; Stip E
Soc Neurosci; 2007; 2(2):106-16. PubMed ID: 18633810
[TBL] [Abstract][Full Text] [Related]
6. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
[TBL] [Abstract][Full Text] [Related]
7. Sensation-seeking, social anhedonia, and impulsivity in substance use disorder patients with and without schizophrenia and in non-abusing schizophrenia patients.
Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Lipp O; Stip E; Potvin S
Psychiatry Res; 2012 Dec; 200(2-3):237-41. PubMed ID: 22980481
[TBL] [Abstract][Full Text] [Related]
8. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
9. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Green AI; Tohen MF; Hamer RM; Strakowski SM; Lieberman JA; Glick I; Clark WS;
Schizophr Res; 2004 Feb; 66(2-3):125-35. PubMed ID: 15061244
[TBL] [Abstract][Full Text] [Related]
10. Differential relationships of PTSD and childhood trauma with the course of substance use disorders.
Mergler M; Driessen M; Havemann-Reinecke U; Wedekind D; Lüdecke C; Ohlmeier M; Chodzinski C; Teunißen S; Weirich S; Kemper U; Renner W; Schäfer I;
J Subst Abuse Treat; 2018 Oct; 93():57-63. PubMed ID: 30126542
[TBL] [Abstract][Full Text] [Related]
11. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.
Wobrock T; Falkai P; Schneider-Axmann T; Hasan A; Galderisi S; Davidson M; Kahn RS; Derks EM; Boter H; Rybakowski JK; Libiger J; Dollfus S; López-Ibor JJ; Peuskens J; Hranov LG; Gaebel W; Fleischhacker WW;
Schizophr Res; 2013 Jun; 147(1):132-139. PubMed ID: 23537477
[TBL] [Abstract][Full Text] [Related]
12. Substance use disorders in individuals with body dysmorphic disorder.
Grant JE; Menard W; Pagano ME; Fay C; Phillips KA
J Clin Psychiatry; 2005 Mar; 66(3):309-16; quiz 404-5. PubMed ID: 15766296
[TBL] [Abstract][Full Text] [Related]
13. Neural correlates of the affect regulation model in schizophrenia patients with substance use history: a functional magnetic resonance imaging study.
Mancini-Marïe A; Potvin S; Fahim C; Beauregard M; Mensour B; Stip E
J Clin Psychiatry; 2006 Mar; 67(3):342-50. PubMed ID: 16649818
[TBL] [Abstract][Full Text] [Related]
14. [Cannabis and schizophrenia: demographic and clinical correlates].
Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
[TBL] [Abstract][Full Text] [Related]
15. Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity.
Marquez-Arrico JE; López-Vera S; Prat G; Adan A
Psychiatry Res; 2016 Mar; 237():1-8. PubMed ID: 26921044
[TBL] [Abstract][Full Text] [Related]
16. Substance use disorder trajectory classes: diachronic integration of onset age, severity, and course.
Clark DB; Jones BL; Wood DS; Cornelius JR
Addict Behav; 2006 Jun; 31(6):995-1009. PubMed ID: 16675151
[TBL] [Abstract][Full Text] [Related]
17. Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
Thoma P; Daum I
Psychiatry Clin Neurosci; 2013 Sep; 67(6):367-83. PubMed ID: 23890122
[TBL] [Abstract][Full Text] [Related]
18. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
Clark RE; Xie H; Brunette MF
J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
[TBL] [Abstract][Full Text] [Related]
20. Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.
Zhornitsky S; Stip E; Desfossés J; Pampoulova T; Rizkallah E; Rompré PP; Bentaleb LA; Lipp O; Chiasson JP; Gendron A; Potvin S
Front Psychiatry; 2011; 2():22. PubMed ID: 21629845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
